Atlas Trials

A Clinical Study to Evaluate the Efficacy and Safety of CKD-351

Clinical trial NCT03762369 · UNKNOWN

Trial details

NCT number
NCT03762369
Sponsor
Chong Kun Dang Pharmaceutical
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Open-angle GlaucomaOcular Hypertension
Start date
2018-12-07
Primary completion
2022-02-28
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.